Fig. 1
Gene expression of ATP-dependent binding cassette transporters. a Microarray analysis of mammary glands from Apc
Min/+ and Apc
+/+ mice at d16 of lactation show a decrease in ABCG2 and increase in MDR1 expression due to Apc mutation. b MDR1 gene expression in cells from MMTV-PyMT;Apc
Min/+ and MMTV-PyMT;Apc
+/+ mice after 24 h treatment with either solvent control, paclitaxel, cisplatin or doxorubicin. MDR1 expression was significantly increased in cells from MMTV-PyMT;Apc
Min/+ mice after treatment with paclitaxel and doxorubicin but not cisplatin. c ABCG2 gene expression in cells from MMTV-PyMT;Apc
Min/+ and MMTV-PyMT;Apc
+/+ mice after treatment for 24 h with either solvent control, paclitaxel, cisplatin or doxorubicin. ABCG2 expression was not different between MMTV-PyMT;Apc
Min/+ and MMTV-PyMT;Apc
+/+ cells and chemotherapy treatment had no effect on ABCG2 expression. d Representative western blots for MDR1 and ABCG2 in cells from MMTV-PyMT;Apc
Min/+ and MMTV-PyMT;Apc
+/+ mice after treatment for 24 h with either solvent control, paclitaxel, cisplatin or doxorubicin. e Quantification of MDR1 western blots shows that MMTV-PyMT;Apc
Min/+ cells have enhanced MDR1 expression when treated with doxorubicin. f Quantification of ABCG2 western blots shows that MMTV-PyMT;Apc
+/+ cells have elevated ABCG2 protein expression compared to MMTV-PyMT;Apc
Min/+ cells. Results in b, c, e and f are shown as the means ± SEM from 3 independent experiments; *P < 0.05 when comparing MMTV-PyMT;Apc
Min/+ to MMTV-PyMT;Apc
+/+ cells and #P < 0.05 when comparing MMTV-PyMT;Apc
Min/+ cells treated with solvent control or chemotherapy agent